| Disease | glioma |
| Comorbidity | C0007137|squamous cell carcinoma |
| Sentences | 1 |
| PubMedID- 25926743 | Nimotuzumab has been approved for the squamous cell carcinoma of head and neck, glioma, and nasopharyngeal cancer in different countries. |
Page: 1